[1] WHO. The top 10 causes of death. 2021. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. [2021–11–5]. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
[2] Wang YJ, Li ZX, Gu HQ, Zhai Y, Jiang Y, Zhao XQ, et al. China stroke statistics 2019: a report from the national center for healthcare quality management in neurological diseases, China national clinical research center for neurological diseases, the Chinese stroke association, national center for chronic and non-communicable disease control and prevention, Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations. Stroke Vasc Neurol 2020;5(3):211 − 39. http://dx.doi.org/10.1136/svn-2020-000457CrossRef
[3] The CPC Central Committee and the State Council. The CPC central committee and the state council issued the “Healthy China 2030 Plan”. 2016. http://www.gov.cn/zhengce/2016-10/25/content_5124174.htm. [2021-12-10]. (In Chinese). http://www.gov.cn/zhengce/2016-10/25/content_5124174.htm
[4] WHO. International statistical classification of diseases and related health problems (ICD). 2022. https://www.who.int/standards/classifications/classification-of-diseases. [2022–5–26].https://www.who.int/standards/classifications/classification-of-diseases
[5] Guo K, Yin P, Wang LJ, Ji YB, Li QF, Bishai D, et al. Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China. Popul Health Metr 2015;13:16. http://dx.doi.org/10.1186/s12963-015-0051-3CrossRef
[6] Ma QF, Li R, Wang LJ, Yin P, Wang Y, Yan CM, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2021;6(12):e897 − 906. http://dx.doi.org/10.1016/s2468-2667(21)00228-0CrossRef
[7] Network GBoDC. Global burden of disease study 2019 (GBD 2019) results. https://vizhub.healthdata.org/gbd-results/. [2021–12–12].
[8] Wang WZ, Wang D, Liu HM, Sun HX, Jiang B, Ru XJ, et al. Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc Neurol. 2017;2(3):132 − 9. http://dx.doi.org/10.1136/svn-2017-000098CrossRef
[9] Wu SM, Wu B, Liu M, Chen ZM, Wang WZ, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019;18(4):394 − 405. http://dx.doi.org/10.1016/s1474-4422(18)30500-3CrossRef
[10] GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021;20(10):795 − 820. http://dx.doi.org/10.1016/s1474-4422(21)00252-0CrossRef
[11] Wang WZ, Jiang B, Sun HX, Ru XJ, Sun DL, Wang LH, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480,687 adults. Circulation 2017;135(8):759 − 71. http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025250CrossRef
[12] Report on Stroke Center in China Writing Group. Brief report on stroke center in China, 2020. Chin J Cerebrovasc Dis 2021;18(11):737 − 43. http://dx.doi.org/10.3969/j.issn.1672-5921.2021.11.001 (In Chinese). CrossRef
[13] Liu JM, Qi JL, Yin P, Liu YN, You JL, Lin L, et al. Cardiovascular disease mortality — China, 2019. China CDC Wkly, 2021;3(15):323 − 6. http://dx.doi.org/10.46234/ccdcw2021.087CrossRef